Literature DB >> 7546696

Ganglion cell death in glaucoma: pathology recapitulates ontogeny.

H A Quigley1.   

Abstract

I review some improvements in our knowledge about the death of retinal ganglion cells in glaucoma during the last 20 years. These include the realisation that glaucoma damage precedes its detection by perimetry, the fact that the lamina cribrosa is a major site of axonal injury to ganglion cells, and the association between regional structure of optic nerve head connective tissue and the pattern of glaucoma damage. The selective susceptibility of larger retinal ganglion cells and its functional significance are described. Apoptosis is the mode of cell death in at least some ganglion cells in experimental glaucoma. This supports a theory that retrograde axonal transport failure leads to loss of trophic factor influence on ganglion cells, causing them to initiate their own suicide. As a consequence of this theory, two therapeutic avenues are suggested for prevention of glaucoma injury and cell death: delivery of trophic factors and manipulation of ganglion cell genetic expression of controlling influences over programmed cell death.

Entities:  

Mesh:

Year:  1995        PMID: 7546696     DOI: 10.1111/j.1442-9071.1995.tb00135.x

Source DB:  PubMed          Journal:  Aust N Z J Ophthalmol        ISSN: 0814-9763


  42 in total

Review 1.  Ganglion cell death in glaucoma: what do we really know?

Authors:  N N Osborne; J P Wood; G Chidlow; J H Bae; J Melena; M S Nash
Journal:  Br J Ophthalmol       Date:  1999-08       Impact factor: 4.638

2.  Preservation of retina ganglion cell function by morphine in a chronic ocular-hypertensive rat model.

Authors:  Shahid Husain; Yasir Abdul; Craig E Crosson
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-28       Impact factor: 4.799

3.  A mouse model of elevated intraocular pressure: retina and optic nerve findings.

Authors:  Ronald L Gross; Jianzhong Ji; Peter Chang; Mark E Pennesi; Zhuo Yang; Jian Zhang; Samuel M Wu
Journal:  Trans Am Ophthalmol Soc       Date:  2003

Review 4.  A biomechanical paradigm for axonal insult within the optic nerve head in aging and glaucoma.

Authors:  Claude F Burgoyne
Journal:  Exp Eye Res       Date:  2010-09-16       Impact factor: 3.467

Review 5.  Premise and prediction-how optic nerve head biomechanics underlies the susceptibility and clinical behavior of the aged optic nerve head.

Authors:  Claude F Burgoyne; J Crawford Downs
Journal:  J Glaucoma       Date:  2008 Jun-Jul       Impact factor: 2.503

6.  Nerve fiber layer thinning lags retinal ganglion cell density following crush axonopathy.

Authors:  Gustavo C Munguba; Sanja Galeb; Yuan Liu; David C Landy; Daisy Lam; Andrew Camp; Sinthia Samad; Mary L Tapia; Richard K Lee
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-09-16       Impact factor: 4.799

7.  Effects of primary glaucoma on sleep quality and daytime sleepiness of patients residing at an equatorial latitude.

Authors:  Jacob Yh Chin; Zhi Hong Toh; Ying Tai Lo; Hannah Ty Wang; Elizabeth Yw Poh; Chun Hau Chua; Owen Kim Hee; Boon Ang Lim; Vernon Ky Yong; Augustinus Laude; Hon Tym Wong; Leonard Wl Yip
Journal:  Int J Ophthalmol       Date:  2020-09-18       Impact factor: 1.779

Review 8.  Neurotrophin roles in retinal ganglion cell survival: lessons from rat glaucoma models.

Authors:  Elaine C Johnson; Ying Guo; William O Cepurna; John C Morrison
Journal:  Exp Eye Res       Date:  2009-02-14       Impact factor: 3.467

9.  A Thy1-CFP DBA/2J mouse line with cyan fluorescent protein expression in retinal ganglion cells.

Authors:  Iona D Raymond; Angela L Pool; Alejandro Vila; Nicholas C Brecha
Journal:  Vis Neurosci       Date:  2009-11-23       Impact factor: 3.241

10.  Deformation of the normal monkey optic nerve head connective tissue after acute IOP elevation within 3-D histomorphometric reconstructions.

Authors:  Hongli Yang; J Crawford Downs; Ian A Sigal; Michael D Roberts; Hilary Thompson; Claude F Burgoyne
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-07-23       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.